Latest News

2024.03.19
Leadgene Biomedical, CYTENA BPS, and CYTENA Forge Tripartite Collaboration to Establish Cell Line Development Platform
Leadgene Biomedical has joined forces with BICO Group's CYTENA in Germany and CYTENA Bioprocess Solutions (CYTENA BPS) to create a cutting-edge, competitive Cell Line Development (CLD) platform. This partnership aims to enhance the precision and technological advancement of cell cultivation through real-time monitoring with automated equipment.
2024.03.14
Innovative Patented In Vitro Diagnostics Receives Market Approval
The "Leadgene Indoxyl Sulfate (IS) ELISA Kit," a cutting-edge protein-bound uremic toxin detection kit, has successfully attained approval from the Taiwan Food and Drug Administration (TFDA) as a third-class In vitro diagnostic (IVDs) (MOHW-MD-No. 007625). This innovation marks the first globally patented indoxyl sulfate IVD, set to revolutionize testing by slashing time and costs, boosting efficiency, introducing novel clinical diagnostic avenues, and aiding kidney disease patients across Taiwan and beyond.
2024.02.17
World Premiere: Leadgene Biomedical's Indoxyl Sulfate (IS) ELISA Kit Secures TFDA Approval
Leadgene Indoxyl Sulfate (IS) ELISA Kit has been officially certified by the Taiwan Food and Drug Administration (TFDA) as a Class III in vitro diagnostic (IVD) device (MOHW-MD-No. 007625). This marks a global first and a pioneering achievement in Taiwan, promising to revolutionize clinical testing with a new solution for the prevention and management of kidney diseases. Aimed at reducing healthcare expenses and enhancing public health, Leadgene is preparing to distribute this innovative solution throughout Taiwan's leading medical centers, hospitals, clinics, and labs.
1
/
3
2024.01.22

Leadgene Biomedical Embraces Openness and Strategic Partnerships for Global Market Expansion
2023.12.25

Nanobody Development: Pioneering Tiny Titans for Next-Generation Biotechnology
2023.11.02

Leadgene Biomedical Achieves Recognition as a Domestic CRO Service Company!
2023.10.03

Leadgene Biomedical CEO Honored with 2023 Best Bio CEO Second Prize & Best Potential Prize
2023.09.06

Leadgene Biomedical Wins 2023 Taipei Biotech Awards - Innovation Special Mention Awards
2023.08.11

Leadgene Biomedical Achieves Milestone Recognition, Paving the Way for Advanced Kidney Disease Diagnostics in Taiwan
2023.07.24

Leadgene Biomedical, Inc. Aims for IPO within Three Years Driven by Reagent Raw Materials and Uremic Toxin Detection Kit
2023.04.27

Indoxyl Sulfate Antibody Secures Second U.S. Patent
2023.03.13

Leadgene Indoxyl Sulfate ELISA Kit Helps Medical Institutions Seize the Golden Treatment Period for Kidney Disease
2022.11.10

31st National Award of Outstanding SMEs Awarded!
2023.03.14

New Distributor Announcement - AS ONE Corporation
2023.02.24

President Tsai meets the winners of the 2022 Taiwan BIO Awards